JP3288132B2 - 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物 - Google Patents

置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物

Info

Publication number
JP3288132B2
JP3288132B2 JP13760593A JP13760593A JP3288132B2 JP 3288132 B2 JP3288132 B2 JP 3288132B2 JP 13760593 A JP13760593 A JP 13760593A JP 13760593 A JP13760593 A JP 13760593A JP 3288132 B2 JP3288132 B2 JP 3288132B2
Authority
JP
Japan
Prior art keywords
pyridyl
group
pyrimidinyl
trifluoromethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP13760593A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0673048A (ja
Inventor
治一 深見
昌樹 橋本
信二郎 庭田
醇 妹背
陽資 川口
俊夫 高橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Suntory Ltd
Original Assignee
Shionogi and Co Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd, Suntory Ltd filed Critical Shionogi and Co Ltd
Priority to JP13760593A priority Critical patent/JP3288132B2/ja
Priority to CA002098650A priority patent/CA2098650A1/en
Priority to AU41326/93A priority patent/AU658306B2/en
Priority to DE69327074T priority patent/DE69327074T2/de
Priority to EP93304858A priority patent/EP0576251B1/en
Priority to TW082105041A priority patent/TW303366B/zh
Priority to US08/079,925 priority patent/US5424310A/en
Priority to KR1019930011559A priority patent/KR100299396B1/ko
Priority to BR9302641A priority patent/BR9302641A/pt
Publication of JPH0673048A publication Critical patent/JPH0673048A/ja
Application granted granted Critical
Publication of JP3288132B2 publication Critical patent/JP3288132B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP13760593A 1992-06-25 1993-06-08 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物 Expired - Fee Related JP3288132B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP13760593A JP3288132B2 (ja) 1992-06-25 1993-06-08 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物
CA002098650A CA2098650A1 (en) 1992-06-25 1993-06-17 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
AU41326/93A AU658306B2 (en) 1992-06-25 1993-06-18 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
EP93304858A EP0576251B1 (en) 1992-06-25 1993-06-22 Substituted 1,2,4-triazine-3,5-dione derivatives and drug compositions containing them, particularly for coccidiosis treatment
DE69327074T DE69327074T2 (de) 1992-06-25 1993-06-22 Substituierte 1,2,4-Triazine-3,5-Dion Derivate und diese enthaltende Arzneimittel, insbesondere zur Behandlung von Coccidiose
TW082105041A TW303366B (enExample) 1992-06-25 1993-06-23
US08/079,925 US5424310A (en) 1992-06-25 1993-06-23 Substituted 1,2,4-triazine-3,5-dione derivative and anticoccidial drug composition containing the same as active component
KR1019930011559A KR100299396B1 (ko) 1992-06-25 1993-06-24 치환된1,2,4-트리아진-3,5-디온유도체및활성성분으로이를함유한구충류구제용약물조성물
BR9302641A BR9302641A (pt) 1992-06-25 1993-06-24 Derivado de 1,2,4-triazina-3,5-diona substituida ou sal do mesmo,composicao para droga anticoccidiana e processo para a preparacao do dito derivado ou sal

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP16783792 1992-06-25
JP4-167837 1992-06-25
JP13760593A JP3288132B2 (ja) 1992-06-25 1993-06-08 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物

Publications (2)

Publication Number Publication Date
JPH0673048A JPH0673048A (ja) 1994-03-15
JP3288132B2 true JP3288132B2 (ja) 2002-06-04

Family

ID=26470855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13760593A Expired - Fee Related JP3288132B2 (ja) 1992-06-25 1993-06-08 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物

Country Status (9)

Country Link
US (1) US5424310A (enExample)
EP (1) EP0576251B1 (enExample)
JP (1) JP3288132B2 (enExample)
KR (1) KR100299396B1 (enExample)
AU (1) AU658306B2 (enExample)
BR (1) BR9302641A (enExample)
CA (1) CA2098650A1 (enExample)
DE (1) DE69327074T2 (enExample)
TW (1) TW303366B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
US5747476A (en) * 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
DE102009038949A1 (de) * 2009-08-26 2011-03-03 Bayer Animal Health Gmbh Neue Verwendung von heterocyclisch substituierten 1,2,4-Triazindionen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1448696A (en) * 1973-05-29 1976-09-08 Pfizer 2-phqnyl-astriazine-3,4-2h,4h-diones
DE2532363A1 (de) * 1975-07-19 1977-02-03 Bayer Ag Substituierte 2-phenyl-1,2,4- triazin-3,5(2h,4h)-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2606850A1 (de) * 1976-02-20 1977-09-15 Hoechst Ag Substituierte p-aminophenyl-as- triazindione und ihre herstellung
DE3805660A1 (de) * 1988-02-24 1989-09-07 Bayer Ag Substituierte 1,2,4-triazindione, verfahren zu ihrer herstellung und ihre verwendung
DE3814323A1 (de) * 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
US5214043A (en) * 1989-01-09 1993-05-25 Bayer Aktiengesellschaft Parasiticidal substituted hexahydro-1,2,4-triazinediones
EP0377903A3 (de) * 1989-01-09 1991-07-17 Bayer Ag Substituierte Hexahydro-1,2,4-triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3912723A (en) 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones

Also Published As

Publication number Publication date
KR100299396B1 (ko) 2001-11-22
AU658306B2 (en) 1995-04-06
AU4132693A (en) 1994-01-06
KR940005618A (ko) 1994-03-21
DE69327074T2 (de) 2000-03-16
EP0576251A1 (en) 1993-12-29
EP0576251B1 (en) 1999-11-24
JPH0673048A (ja) 1994-03-15
CA2098650A1 (en) 1993-12-26
US5424310A (en) 1995-06-13
DE69327074D1 (de) 1999-12-30
TW303366B (enExample) 1997-04-21
BR9302641A (pt) 1994-02-16

Similar Documents

Publication Publication Date Title
DE60103976T2 (de) Pyrimidinylcarboxamiden als inhibitoren der pde4 isoenzyme
DE60110205T2 (de) Nicotinamide benzoanellierte-heterocyclische derivate als selektive inhibitoren der pde4 isoenzyme
AU2002363176B2 (en) Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
DE60203652T2 (de) Nikotinsäureamid-Derivate und ihre Mimetika als Inhibitoren von PDE4-Isozyme
CN102099036B (zh) 用于治疗炎性疾患和纤维化疾患的化合物和方法
DE60029235T2 (de) Fab-i-hemmer
AU2002363176A1 (en) Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
DE2147794A1 (de) Neue Triazole und diese enthaltende Zubereitungen
JP2008516902A5 (enExample)
JPH0710848B2 (ja) ピリジン−３−カルボキサミド誘導体
US4659720A (en) 5-amino or substituted amino imidazoles useful to treat coccidiosis
EP0112707B1 (en) Aminopyrimidinone derivatives as histamine h1-antagonists
AU582214B2 (en) Anthelmintic pyridinyl acylhydrazones, method of use and compositions
JP3288132B2 (ja) 置換１，２，４−トリアジン−３，５−ジオンおよびそれを有効成分とする抗コクシジウム組成物
JPH0345073B2 (enExample)
FR2464264A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones, leur preparation et leur utilisation therapeutique
CN106660961A (zh) 作为抗蠕虫药的新的磺酰基氨基苯甲酰胺化合物
JP2003012667A (ja) キノリンカルボキサミド骨格を有する抗菌剤
DD146953A5 (de) Verfahren zur herstellung von pyrimidonderivaten
JPS60188375A (ja) ５‐アミノまたは置換アミノ１，２，３‐トリアゾール
AU681694B2 (en) Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
JP2016535017A (ja) 新規な抗真菌性オキソジヒドロピリジンカルボヒドラジド誘導体
US4816469A (en) 5-Amino or substituted amino 1,2,3-triazoles
JP2003502413A (ja) 農薬活性テトラジン誘導体
JPH03261783A (ja) １，２，４―トリアジンジオン化合物及びそれを有効成分とする抗コクシジウム剤

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees